References
- Cuellar F. G. Bromocriptine mesylate (Parlodel) in the management of amenorrheagalactorrhea associated with hyperprolactinemia. Obstet. Gynecol. 1980; 55: 278–84
- Friesen H., Tohs G. Use of bromocriptine in the galactorrhea-amenorrhea syndrome. The Canadian Cooperative Study. Clin. Endocrinol. (Oxf.) 1977; 6: 915, Suppl.
- Metha A. E., Tolis G. Pharmacology of bromocriptine in health and disease. Drugs 1979; 17: 313–25
- Schran H. F., Bhuta S. I., Schwarz H. J., Thorner M. O. The pharmacokinetics of bromocriptine in man. Ergot Compounds and Brain Function: Neuroendocrine and Neuropsychiatric Aspects, M. Goldstein, D. Calne, A. Leiberman, M. O. Thorner. Raven Press, New York 1980; 125–39
- Montini M., Pagani G., Gianola D., Montini M., Pagani G., Gianola D., Pagani M. D., Salmoiraghi M., Ferrari L., Lancranjan I. Long-lasting suppression of prolactin secretion and rapid shrinkage of prolactinomas after a long-acting, injectable form of bromocriptine. J. Clin. Endocrinol. Metab. 1986; 63: 266–8
- Rolland R. On Parlodelr` LAR and optimal treatment of hyperprolactinemia. New Aspects of Dopamine Agonist Therapy in Menstrual Cycle Disorders and Infertility, R. J. Pepperel. Parthenon Publishing, CarnforthUK 1990; 33–46
- Vermesh M., Fossum G. T., Kletzky O. A. Vaginal bromocriptine: pharmacology and effect on serum prolactin in normal women. Obstet. Gynecol. 1988; 72: 693–8
- Katz E., Weiss B. E., Hassell A., Schran H. F., Adashi E. Y. Increased circulating levels of bromocriptine after vaginal compared with oral administration. Fertil. Steril. 1991; 55: 882–4
- Sarkar M. A. Drug metabolism in the nasal mucosa. Pharmacol. Res. 1992; 9: 1–9
- Cicinelli E., Ragno G., Cagnazzo I., Fanelli F., Vetuschi C., Schonauer S. Progesterone administration by nasal spray. Fertil. Steril. 1991; 56: 139–41
- Gopinath P. G., Gopinath R. D., Anand Kumar T. C. Target site of intranasally sprayed substances and their transport across the nasal mucosa: a new insight into intranasal route of drug delivery. Curr. Ther. Res. 1978; 23: 596–607
- Rosenthaler J., Munzer H., Voges R. Immunoassay of bromocriptine and specificity of antibody: criteria for choice of antiserum and marker compound. Drug Metabolite Isolation and Determination, E. Reid, J. P. Leppard. Plenum Press, New York 1983; 215–23
- Jagannadha R. A., Moudal N. R., Li C. H. β-Endorphin: intranasal administration increases the serum prolactin level in monkeys. Int. J. Pept. Protein Res. 1986; 28: 546–8
- Faraj J. A., Hussain A. A., Aramaki Y., Iseki K., Kagoshima M., Dittert L. W. Mechanism of nasal absorption of drugs, III. Nasal absorption of leucine enkephalin. J. Pharmacol. Sci. 1990; 79: 698–702